TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012
TCL Archive Shift Of $6.5 Million From Contracts to Pay Core, P01s At Recommended Levels, Increase R01 Payline June 27, 1980
TCL Archive As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data. October 22, 2004
TCL Archive NCAB Asks NCI To Delay Proposed change In Breast Cancer Screening Guidelines November 26, 1993
